Stocks/NKTX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

NKTX

↓ PDF (Pro)
Nkarta Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$3.27
+6.01%today
MKT CAP
$233M
+40.9% · 1Y
Earnings History
+4.4%
+11.4%
+4.4%
-25.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$3.27
Low
$8.00
Analyst Mean
$14.20
High
$25.00
5 analystsNone
Full Financials
Trailing P/E-
Forward P/E-1.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership4.9%
Institutional Ownership78.1%
Short % of Float10.03%
Days to Cover9.5d
1 Week+7.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
HASTINGS PAUL JChief Executive OfficerSale26,046$2.07$0.05M2026-01-15
MAHMOOD NADIR AHMEDUDDINPresidentSale5,649$2.07$0.01M2026-01-15
HASTINGS PAUL JChief Executive OfficerStock94,000$0.00$0.00M2026-01-06
MAHMOOD NADIR AHMEDUDDINPresidentStock80,000$0.00$0.00M2026-01-06
ROSE SHAWN MARSHALLOfficerStock70,000$0.00$0.00M2026-01-06
Top Holders
HolderType% HeldValueΔ SharesAs of
RA Capital Management, L.P.institution15.16%$0.03B+0.00%2025-12-31
Blackrock Inc.institution5.77%$0.01B+11.26%2025-12-31
NEA Management Company, LLCinstitution5.01%$0.01B+0.00%2025-12-31
Samsara BioCapital, LLCinstitution4.92%$0.01B-6.91%2025-12-31
SR One Capital Management, LPinstitution4.68%$0.01B+0.00%2025-12-31
GSK plcinstitution4.42%$0.01B+100.00%2025-12-31
Vanguard Group Incinstitution3.64%$0.01B+4.24%2025-12-31
Monaco Asset Management SAMinstitution3.57%$0.01B+29.23%2025-12-31
Alyeska Investment Group, L.p.institution2.92%$0.01B+0.01%2025-12-31
Renaissance Technologies, LLCinstitution2.39%$0.01B+48.64%2025-12-31
WASATCH FUNDS TRUST-Wasatch Ultra Growth Fundfund2.09%$0.00B+0.00%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund1.99%$0.00B-0.31%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund1.54%$0.00B+0.68%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.78%$0.00B+15.14%2025-12-31
iShares Trust-iShares Russell 2000 Value ETFfund0.58%$0.00B+15.49%2026-03-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.58%$0.00B-0.40%2026-02-28
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.39%$0.00B-0.36%2026-02-28
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fundfund0.29%$0.00B+0.77%2026-02-28
Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETFfund0.20%$0.00B+0.87%2026-03-31
iShares Trust-iShares Micro-Cap ETFfund0.16%$0.00B+3.44%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for NKTX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.